Publikationer pr. år
Publikationer pr. år
Personlig profil
Expertise
Lung cancer.
Lung cancer radiotherapy and lung stereotactic ablative body radiotherapy (SABR).
Motion management in radiotherapy including deep inspiration breath hold radiotherapy.
Image guided radiotherapy.
Primære forskningsområder
Lung cancer radiotherapy and lung stereotactic ablative body radiotherapy (SABR).
Breathing adapted radiotherapy including deep inspiration breath hold radiotherapy.
Radiopaque markers for precision radiotherapy.
Uncertainties in radiotherapy planning and delivery.
Artifact managing in imaging for radiotherapy.
Impact of treatment uncertainties on delivered dose in proton therapy.
Aktuel forskning
INHALE - prospective study of deep inspiration breath-hold radiotherapy for locally advanced non-small cell lung cancer supported by grant from the Danish Cancer Society (R90-A6009-14-S2).
BioXmark - injectable marker for radiotherapy image guidance.
HILUS - Nordic multi center study on SABR of central lung tumors.
PET-boost - European multi center study on dose escalation in radiotherapy of locally advanced non-small cell lung cancer.
Retrospective studies on survival after palliative cerebral and thoracic radiotherapy.
Retrospective studies on survival and toxicity after lunge cancer radiotherapy with curative aim.
APRIL - impact of motion management on PET/CT for radiotherapy planning.
Impact of treatment uncertainties on delivered dose in proton therapy.
Mulige interessekonflikter
None
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Gitte F. Persson er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
- 1 Lignende profiler
Netværk
Seneste eksterne samarbejde på lande-/områdeniveau. Dyk ned i detaljerne ved at klikke på prikkerne eller
-
18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): results from a randomised clinical trial
Cooke, S. A., Dirk de Ruysscher, P., Reymen, B., Lambrecht, M., Fredberg Persson, G., Faivre-Finn Frcr, C., Dieleman, E. M. T., Lewensohn, R., van Diessen, J. N. A., Sikorska, K., Lalezari, F., Vogel, W., van Elmpt, W., Damen, E. M. F., Sonke, J-J. & Belderbos, J. S. A., 2023, I: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 181, s. 1-8 8 s., 109492.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): a study protocol
Spindler, N. J., Persson, G. F., Theile, S., Nielsen, D. L., Høgdall, E. V., Al-Farra, G., Hendel, H. W., Lorentzen, T., Svane, I. M., Lindberg, H. & Eefsen, R. L., 30 jan. 2023, I: BMJ Open. 13, 1, s. e063500 e063500.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Active use of electronic patient-reported outcome in kidney cancer and effect on self-reported physical function: PRORECECA study protocol
Rasmussen, I. M. L., Moeller, A. K. H., Soerensen, A. V., Persson, G., Taarnhoej, G. A., Palshof, J. A. & Pappot, H., dec. 2022, I: Acta Oncologica. 61, 12, s. 1473-1476 4 s.Publikation: Bidrag til tidsskrift › Letter › peer review
-
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study
Mouritzen, M. T., Junker, K. F., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A-C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L., & 7 flere, apr. 2022, I: Acta Oncologica. 61, 4, s. 409-416 8 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
5 Citationer (Scopus) -
Correction: Christensen et al. Impact of [18F]FDG-PET and [18F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. Diagnostics 2021, 11, 279
Christensen, T. N., Langer, S. W., Persson, G., Larsen, K. R., Amtoft, A. G., Keller, S. H., Kjaer, A. & Fischer, B. M., 18 jul. 2022Publikation: Andet › Andet bidrag › Forskning